Diphtheria  Archives

 Diphtheria
Reassurance of population immunity to diphtheria in England: Results from a 2021 national serosurvey

Published on 21/04/2026 |  Original article (Abstract)  | Vusirikala, Amoolya et al. | Vaccine 2023; 41(2 November 2023): 6878-83 1 min.

Diphtheria is rare in England because of an effective national immunisation schedule that includes 5 doses of a diphtheria-containing vaccine at 2, 3, 4 months, preschool and adolescent boosters. However, in recent years there has been a notable increase in cases due to Corynebacterium ulcerans...

 Diphtheria
Half-life estimation of pertussis-specific maternal antibodies in (pre)term infants after in-pregnancy tetanus, diphtheria, acellular pertussis vaccination

Published on 20/01/2026 |  Original article (Abstract)  | Stefan Embacher et al. | The Journal of infectious diseases 2023; 228(11): 1640-8 1 min.

To reduce the risk of pertussis related morbidity and mortality in early life, an increasing number of countries recommend maternal pertussis vaccination. Hence, there is limited knowledge about half-lives of vaccine-induced pertussis-specific maternal antibodies, especially in preterm infants and factors...

 Diphtheria
Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature

Published on 20/01/2026 |  Original article (Abstract)  | Meichen Pan et al. | Human vaccines & immunotherapeutics 2023; 19(2): 1 min.

A 20-month-old girl was diagnosed with Guillain – Barré syndrome (GBS) based on progressive muscle weakness, areflexia, and albuminocytologic dissociation of the cerebrospinal fluid. Despite timely and systematic treatment, she eventually became paralyzed. There is a temporal correlation...

 Diphtheria
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India

Published on 20/01/2026 |  Original article (Abstract)  | Sharma Hitt J et al. | Expert Review of Vaccines 2023; 22(1): 278-87 1 min.

This study assessed safety and immunogenicity of Serum Institute of India Pvt Ltd (SIIPL)'s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster vaccine (Tdap). In this Phase II/III, multicenter, randomized, active-controlled, open-label study, 1500 healthy individuals, aged 4–65...

 Diphtheria
Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and rising background C. diphtheriae cases—Seattle, Washington 2020-2023

Published on 20/01/2026 |  Original article (Abstract)  | Ellora N Karmarkar et al. | Clinical infectious diseases 2024; 78(5): 1-8 1 min.

Non-toxigenic Corynebacterium diphtheriae (C. diphtheriae), often associated with wounds, can rarely cause infective endocarditis (IE). Five patients with C. diphtheriae IE were identified within 12 months at a Seattle-based hospital system. We reviewed prior C. diphtheriae...